½ÃÀ庸°í¼­
»óǰÄÚµå
1790465

¹Ì±¹ÀÇ ¿©¼º¿ë ü¿Ü Ä«Å×ÅÍ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ¿ëµµº°, ¿ä½Ç±Ý ºÎÀ§º°, ÃÖÁ¾ ¿ëµµº°, ºÎ¹®º° ¿¹Ãø(2025-2033³â)

U.S. Female External Catheter Market Size, Share & Trends Analysis Report By Application (Diabetes, Strokes, Ovarian Cancer, Bladder Cancer), By Area Of Incontinence, By End-use, And Segment Forecasts, 2025 - 2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 300 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¹Ì±¹ÀÇ ¿©¼º¿ë ü¿Ü Ä«Å×ÅÍ ½ÃÀå °³¿ä

¹Ì±¹ÀÇ ¿©¼º¿ë ü¿Ü Ä«Å×ÅÍ ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 4¾ï 4,265¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2033³â¿¡´Â 8¾ï 743¸¸ ´Þ·¯¿¡ ´ÞÇϰí, 2025-2033³â 7.09%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº ƯÈ÷ °í·ÉÈ­ »çȸ¿¡¼­ ¿©¼ºÀÇ ¿ä½Ç±Ý À¯º´·ü Áõ°¡, ºñħ½ÀÀû ¹è´¢ °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ Àνİú äÅà Áõ°¡, Àå±â ¿ä¾ç ¹× º´¿ø ȯ°æ¿¡¼­ÀÇ À§»ý ¹× ÆíÀǼº Çâ»ó¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µîÀÔ´Ï´Ù.

¶ÇÇÑ, ÀçÅÃÄ¡·á ¼­ºñ½º·ÎÀÇ Àüȯ°ú ¿©¼º¿ë ü¿Ü Ä«Å×ÅÍ ¼³°èÀÇ ¹ßÀüÀº ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹ Àα¸Á¶»ç±¹ÀÌ ¹ßÇ¥ÇÑ Vintage 2024 Population Estimates¿¡ µû¸£¸é, 2024³â¿¡´Â ¿©¼ºÀÌ ¹Ì±¹ Àüü Àα¸ÀÇ 50.5%¸¦ Â÷ÁöÇØ ³²¼ºº¸´Ù ¾à 340¸¸ ¸í ´õ ¸¹À» °ÍÀ¸·Î ¿¹»óÇß½À´Ï´Ù.

ÀÌ·¯ÇÑ ÁúȯÀº ¹æ±¤ ±â´É Àå¾Ö ¹× ¿ä½Ç±Ý°ú °°Àº ¹è´¢ ÇÕº´Áõ°ú °ü·ÃÀÌ ÀÖÀ¸¸ç, ƯÈ÷ °í·ÉÀÚ ¹× ¸¸¼º Áúȯ ȯÀÚÀÇ °æ¿ì Æí¾ÈÇÔ, À§»ý ¹× »îÀÇ ÁúÀ» À¯ÁöÇϱâ À§ÇØ ºñħ½ÀÀûÀ̰í ȯÀÚ Ä£È­ÀûÀÎ °ü¸® ¼Ö·ç¼ÇÀÌ ÇÊ¿äÇÕ´Ï´Ù. Diabetes, Obesity, and MetabolismÁö°¡ 2024³â 8¿ù¿¡ ¹ßÇ¥ÇÑ ÀÚ·á¿¡ µû¸£¸é, ¹Ì±¹ ¼ºÀÎ Áß ¾à 9,600¸¸ ¸íÀÌ ¿¹ºñ ´ç´¢º´ ȯÀÚÀ̸ç, 3,700¸¸ ¸íÀÌ ´ç´¢º´ Áø´ÜÀ» ¹Þ¾Ò´Ù°í ÇÕ´Ï´Ù. 2022³â ¿©¼º ´ç´¢º´ À¯º´·üÀº 11.56%·Î ¿©¼º Àα¸¿¡ Å« ºÎ´ãÀ» ÁÖ°í ÀÖ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.

¶ÇÇÑ, ³­¼Ò¾ÏÀº ¹Ì±¹ ¿©¼ºµé¿¡°Ô ¿©ÀüÈ÷ ½É°¢ÇÑ °Ç°­ ¹®Á¦À̸ç, ÇâÈÄ ¼ö½Ê³âµ¿¾È ȯÀÚ ¼ö°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ·¯ÇÑ À¯ÇüÀÇ ¾ÏÀº ƯÈ÷ ¼ö¼úÀ̳ª Ä¡·á ÈÄ ¹è´¢ Àå¾Ö¸¦ À¯¹ßÇÒ ¼ö ÀÖ¾î ¿©¼º¿ë ü¿Ü Ä«Å×ÅÍ¿Í °°Àº ¹è´¢ °ü¸® Á¦Ç°ÀÇ Çʿ伺ÀÌ ´õ¿í Ä¿Áö°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¹Ì±¹ÀÇ ¿©¼º¿ë ü¿Ü Ä«Å×ÅÍ ½ÃÀå º¯¼ö, µ¿Çâ ¹× ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • º¸Á¶ ½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
    • ½ÃÀå ±âȸ ºÐ¼®
    • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦ ºÐ¼®
  • ¹Ì±¹ÀÇ ¿©¼º¿ë ü¿Ü Ä«Å×ÅÍ ½ÃÀå ºÐ¼® Åø
    • »ê¾÷ ºÐ¼® - PorterÀÇ Five Forces ºÐ¼®
    • PESTEL ºÐ¼®

Á¦4Àå ¹Ì±¹ÀÇ ¿©¼º¿ë ü¿Ü Ä«Å×ÅÍ ½ÃÀå : ¿ëµµº°, ÃßÁ¤ ¹× µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¹Ì±¹ÀÇ ¿©¼º¿ë ü¿Ü Ä«Å×ÅÍ ½ÃÀå ¿ëµµ º¯µ¿ ºÐ¼®
  • ¹Ì±¹ÀÇ ¿©¼º¿ë ü¿Ü Ä«Å×ÅÍ ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®(¿ëµµº°, 2021-2033³â)
  • ´ç´¢º´
  • ³úÁ¹Áß
  • ¾ËÃ÷ÇÏÀ̸Ӻ´
  • ÆÄŲ½¼º´
  • ô¼ö ¼Õ»ó
  • ¹æ±¤¾Ï
  • ³­¼Ò¾Ï
  • ´Ù¹ß¼º °æÈ­Áõ
  • ±âŸ

Á¦5Àå ¹Ì±¹ÀÇ ¿©¼º¿ë ü¿Ü Ä«Å×ÅÍ ½ÃÀå : ¿ä½Ç±Ý ºÎÀ§º°, ÃßÁ¤ ¹× µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¹Ì±¹ÀÇ ¿©¼º¿ë ü¿Ü Ä«Å×ÅÍ ½ÃÀå ¿ä½Ç±Ý ºÎÀ§ º¯µ¿ ºÐ¼®
  • ¹Ì±¹ÀÇ ¿©¼º¿ë ü¿Ü Ä«Å×ÅÍ ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®(¿ä½Ç±Ý ºÎÀ§º°, 2021-2033³â)
  • º¹¾Ð¼º ¿ä½Ç±Ý
  • Àý¹Ú¼º ¹æ±¤/OAB(°ú¹Î¼º ¹æ±¤)
  • ¿À¹öÇ÷οì
  • ±â´ÉÀû
  • È¥ÇÕ
  • ÁßÁõ ¿ä½Ç±Ý
  • ¹Ý»ç

Á¦6Àå ¹Ì±¹ÀÇ ¿©¼º¿ë ü¿Ü Ä«Å×ÅÍ ½ÃÀå : ÃÖÁ¾ ¿ëµµº°, ÃßÁ¤ ¹× µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¹Ì±¹ÀÇ ¿©¼º¿ë ü¿Ü Ä«Å×ÅÍ ½ÃÀå ÃÖÁ¾ ¿ëµµ º¯µ¿ ºÐ¼®
  • ¹Ì±¹ÀÇ ¿©¼º¿ë ü¿Ü Ä«Å×ÅÍ ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®(ÃÖÁ¾ ¿ëµµº°, 2021-2033³â)
  • ÀçÅÃÄ¡·á
  • º´¿ø
  • ±âŸ

Á¦7Àå °æÀï ±¸µµ

  • ½ÃÀå ÁøÃâ±â¾÷ ºÐ·ù
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • BD
    • Stryker
    • Boehringer Laboratories, LLC.
    • Consure Medical
    • Medline Industries, LP.
    • Ur24Technology, Inc.
    • TillaCare Ltd.
  • 2024³â ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ¿¹Ãø ºÐ¼®
  • ±âŸ ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷ ¸®½ºÆ®
LSH 25.08.20

U.S. Female External Catheter Market Summary

The U.S. female external catheter market size was estimated at USD 442.65 million in 2024 and is projected to reach USD 807.43 million by 2033, growing at a CAGR of 7.09% from 2025 to 2033. The market growth is driven by the rising prevalence of urinary incontinence among women, especially in the aging population, increasing awareness and adoption of non-invasive urinary management solutions, and the growing demand for improved hygiene and comfort in long-term care and hospital settings.

In addition, the shift toward home healthcare services and advancements in female external catheter design further fuel market growth. According to the Vintage 2024 Population Estimates released by the U.S. Census Bureau, in 2024, women accounted for 50.5% of the total U.S. population, overtaking the number of men by approximately 3.4 million.

The increasing prevalence of chronic health conditions, particularly diabetes and ovarian cancer, is anticipated to significantly contribute to the growing demand for female external catheters in the U.S. These conditions are associated with urinary complications, such as bladder dysfunction or incontinence, which require non-invasive and patient-friendly management solutions to maintain comfort, hygiene, and quality of life, especially in elderly and chronically ill patients. According to data published in August 2024 by Diabetes, Obesity, and Metabolism, approximately 96 million U.S. adults are living with prediabetes, while an additional 37 million individuals have been diagnosed with diabetes. The prevalence of diabetes among females stood at 11.56% in 2022, highlighting a substantial burden on the female population.

Furthermore, ovarian cancer remains a critical health issue among U.S. women, with rising case numbers projected over the coming decades. This form of cancer can also lead to urinary dysfunctions, particularly after surgery or treatment, further increasing the need for supportive urinary care products such as female external catheters.

U.S. Female External Catheter Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. female external catheter market report based on application, area of incontinence, and end use:

  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Strokes
  • Alzheimer's Disease
  • Spinal Cord Injury
  • Parkinson's Disease
  • Multiple Sclerosis
  • Bladder Cancer
  • Ovarian Cancer
  • Diabetes
  • Others
  • Area of Incontinence Outlook (Revenue, USD Million, 2021 - 2033)
  • Functional
  • Urge/OAB
  • Severe Incontinence
  • Mixed
  • Stress Urinary Incontinence
  • Overflow
  • Reflex
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Home Care
  • Hospitals
  • Other

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. Area of Incontinence
    • 1.2.3. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
    • 1.5.5. Information Analysis
    • 1.5.6. Data Analysis Models
  • 1.6. Market Formulation & Data Visualization
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Female External Catheter Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing prevalence of urinary incontinence
      • 3.2.1.2. Rising awareness about UI and its treatment options
      • 3.2.1.3. Increasing burden of chronic diseases
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Alternative treatment options
      • 3.2.2.2. Product recalls
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Launches of advanced female external catheters
      • 3.2.3.2. Growing clinical trials for external catheters
      • 3.2.3.3. Rising preferences for female external catheters
      • 3.2.3.4. Patent approvals and strategic collaborations boost market visibility and expansion
    • 3.2.4. Market Challenges Analysis
      • 3.2.4.1. Adverse events and complications associated with the female external catheters
  • 3.3. U.S. Female External Catheter Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. U.S. Female External Catheter Market: Application Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Female External Catheter Market Application Movement Analysis
  • 4.3. U.S. Female External Catheter Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 4.4. Diabetes
    • 4.4.1. Diabetes U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Strokes
    • 4.5.1. Strokes U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Alzheimer's disease
    • 4.6.1. Alzheimer's disease U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Parkinson's disease
    • 4.7.1. Parkinson's disease U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Spinal Cord Injury
    • 4.8.1. Spinal Cord Injury U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9. Bladder Cancer
    • 4.9.1. Bladder Cancer U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.10. Ovarian Cancer
    • 4.10.1. Ovarian Cancer U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.11. Multiple Sclerosis
    • 4.11.1. Multiple Sclerosis U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.12. Others
    • 4.12.1. Others U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Female External Catheter Market: Area of Incontinence Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Female External Catheter Market Area of Incontinence Movement Analysis
  • 5.3. U.S. Female External Catheter Market Size & Trend Analysis, by Area of Incontinence, 2021 to 2033 (USD Million)
  • 5.4. Stress Urinary Incontinence
    • 5.4.1. Stress Urinary Incontinence U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Urge/OAB (Overactive Bladder)
    • 5.5.1. Urge/OAB (Overactive Bladder) U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Overflow
    • 5.6.1. Overflow U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Functional
    • 5.7.1. Functional U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Mixed
    • 5.8.1. Mixed U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Severe Incontinence
    • 5.9.1. Severe Incontinence U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.10. Reflex
    • 5.10.1. Reflex U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Female External Catheter Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Female External Catheter Market End Use Movement Analysis
  • 6.3. U.S. Female External Catheter Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Home Care
    • 6.4.1. Home Care U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Hospitals
    • 6.5.1. Hospitals U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Other End Use
    • 6.6.1. Other End Use U.S. Female External Catheter Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Key Company Profiles
    • 7.2.1. BD
      • 7.2.1.1. Company Overview
      • 7.2.1.2. Financial Performance
      • 7.2.1.3. Product Benchmarking
      • 7.2.1.4. Strategic Initiatives
    • 7.2.2. Stryker
      • 7.2.2.1. Company Overview
      • 7.2.2.2. Financial Performance
      • 7.2.2.3. Product Benchmarking
      • 7.2.2.4. Strategic Initiatives
    • 7.2.3. Boehringer Laboratories, LLC.
      • 7.2.3.1. Company Overview
      • 7.2.3.2. Financial Performance
      • 7.2.3.3. Product Benchmarking
      • 7.2.3.4. Strategic Initiatives
    • 7.2.4. Consure Medical
      • 7.2.4.1. Company Overview
      • 7.2.4.2. Financial Performance
      • 7.2.4.3. Product Benchmarking
      • 7.2.4.4. Strategic Initiatives
    • 7.2.5. Medline Industries, LP.
      • 7.2.5.1. Company Overview
      • 7.2.5.2. Financial Performance
      • 7.2.5.3. Product Benchmarking
      • 7.2.5.4. Strategic Initiatives
    • 7.2.6. Ur24Technology, Inc.
      • 7.2.6.1. Company Overview
      • 7.2.6.2. Financial Performance
      • 7.2.6.3. Product Benchmarking
      • 7.2.6.4. Strategic Initiatives
    • 7.2.7. TillaCare Ltd.
      • 7.2.7.1. Company Overview
      • 7.2.7.2. Financial Performance
      • 7.2.7.3. Product Benchmarking
      • 7.2.7.4. Strategic Initiatives
  • 7.3. Estimated Company Market Share Analysis, 2024
  • 7.4. List of Other Key Market Players
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦